Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2

In this article of EBioMedicine, Santosh Renuse and colleagues(1) show the relevance of combining immunoaffinity capture with targeted mass spectrometry measurement to detect SARS-CoV-2 nucleocapsid proteins in nasopharyngeal swab samples. The COVID-19 pandemic has confirmed the need to improve the...

Descripción completa

Detalles Bibliográficos
Autor principal: Armengaud, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270654/
https://www.ncbi.nlm.nih.gov/pubmed/34252697
http://dx.doi.org/10.1016/j.ebiom.2021.103480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270654/
https://www.ncbi.nlm.nih.gov/pubmed/34252697
http://dx.doi.org/10.1016/j.ebiom.2021.103480

Ejemplares similares